Leukemia drug shows potential against metastatic HER2-positive breast cancer

In animal studies led by researchers at Duke Cancer Institute, a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

source https://medicalxpress.com/news/2022-08-leukemia-drug-potential-metastatic-her2-positive.html